Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have emerged as a revolutionary class of drugs with far-reaching protective effects in multiple organs. The protective potential of SGLT2i is much broader than that of the classical concept of glucose control and consists of an entire conglomerate o...

詳細記述

書誌詳細

出版年:	Инновационная медицина Кубани
主要な著者:	A. A. Avagimyan, M. Sheibani, A. I. Trofimenko, E. E. Lysov, F. M. Khamidova, A. Z. Aznauryan, L. M. Sukiasyan, K. T. Sahakyan, T. R. Gevorgyan, M. R. Tatoyan, G. L. Mkrtchyan, G. L. Meltonyan, A. R. Petrosyan, L. A. Martemyanova, R. R. Petrosyan, O. I. Urazova, N. V. Pogosova, N. Sarrafzadegan
フォーマット:	論文
言語:	英語
出版事項:	Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2024-11-01
主題:	sglt2i cardioprotection nephroprotection dapagliflozin empagliflozin
オンライン･アクセス:	https://www.innovmedkub.ru/jour/article/view/979